Price Alert

Bolt Biotherapeutics Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

6.17

-0.23 (-3.59%)

At close: Oct 09, 2025, 10:53 AM

-3.59% (1D)

Bid	6.17
Market Cap	11.82M
Revenue (ttm)	28.26M
Net Income (ttm)	-50.71M
EPS (ttm)	-26.42
PE Ratio (ttm)	-0.23
Forward PE	-0.27
Analyst	Hold
Dividends	n/a

Ask	6.32
Volume	12,177
Avg. Volume (20D)	22,934
Open	6.45
Previous Close	6.40
Day's Range	6.11 - 6.45
52-Week Range	4.59 - 14.36
Beta	0.91
Ex-Dividend Date	n/a

About BOLT

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BOLT

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BOLT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Bolt Biotherapeutics Inc. is scheduled to release its earnings on Nov 11, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

News

1 month ago · zacks.com

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago.